Ambev S.A. (NYSE:ABEV - Get Free Report) insider De Lacerda Eduardo Cavalcanti sold 152,386 shares of the stock in a transaction dated Friday, March 27th. The stock was sold at an average price of $2.85, for a total transaction of $434,300.10. Following the completion of the transaction, the insider directly owned 223,340 shares of the company's stock, valued at $636,519. This trade represents a 40.56% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website.
Ambev Price Performance
Shares of Ambev stock traded down $0.03 during midday trading on Monday, hitting $3.17. 23,352,807 shares of the company traded hands, compared to its average volume of 25,069,717. The firm's fifty day moving average price is $2.98 and its 200-day moving average price is $2.63. The stock has a market cap of $49.87 billion, a price-to-earnings ratio of 17.58, a PEG ratio of 2.35 and a beta of 0.66. Ambev S.A. has a 12 month low of $2.10 and a 12 month high of $3.24. The company has a debt-to-equity ratio of 0.03, a quick ratio of 0.73 and a current ratio of 0.96.
Ambev (NYSE:ABEV - Get Free Report) last issued its quarterly earnings data on Friday, February 13th. The company reported $0.05 EPS for the quarter, meeting the consensus estimate of $0.05. Ambev had a net margin of 17.75% and a return on equity of 16.41%. The business had revenue of $4.50 billion during the quarter, compared to the consensus estimate of $4.28 billion. As a group, sell-side analysts forecast that Ambev S.A. will post 0.18 earnings per share for the current year.
Institutional Trading of Ambev
Several institutional investors have recently modified their holdings of ABEV. Integrated Wealth Concepts LLC bought a new stake in shares of Ambev in the first quarter worth $26,000. Millennium Management LLC grew its stake in shares of Ambev by 62.5% in the first quarter. Millennium Management LLC now owns 2,399,472 shares of the company's stock worth $5,591,000 after purchasing an additional 922,566 shares during the last quarter. Goldman Sachs Group Inc. grew its stake in shares of Ambev by 13.2% in the first quarter. Goldman Sachs Group Inc. now owns 5,000,107 shares of the company's stock worth $11,650,000 after purchasing an additional 582,153 shares during the last quarter. Focus Partners Wealth bought a new stake in shares of Ambev in the first quarter worth $33,000. Finally, Acadian Asset Management LLC bought a new stake in shares of Ambev in the first quarter worth $264,000. Institutional investors own 8.13% of the company's stock.
Analyst Ratings Changes
Several equities research analysts recently weighed in on ABEV shares. Weiss Ratings raised Ambev from a "hold (c+)" rating to a "buy (b-)" rating in a report on Thursday, March 5th. Barclays increased their target price on Ambev from $2.50 to $3.00 and gave the company an "equal weight" rating in a research report on Tuesday, February 17th. Finally, Wall Street Zen lowered Ambev from a "buy" rating to a "hold" rating in a research note on Monday, March 30th. One equities research analyst has rated the stock with a Buy rating and five have issued a Hold rating to the company. Based on data from MarketBeat.com, Ambev presently has an average rating of "Hold" and a consensus price target of $2.69.
Check Out Our Latest Analysis on ABEV
Ambev Company Profile
(
Get Free Report)
Ambev NYSE: ABEV is a Brazilian-based beverage company that produces, distributes and markets a broad portfolio of alcoholic and non-alcoholic drinks. The company's core business centers on brewing and selling beer, alongside a range of soft drinks, bottled water, energy drinks and other malt-based beverages. Headquartered in São Paulo, Ambev operates an integrated value chain that covers manufacturing, packaging, logistics and commercial sales to retail, on-premise and institutional customers.
The company traces its origins to the 1999 merger of two historic Brazilian breweries, and later became part of the broader global brewing group through subsequent industry consolidations.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Ambev, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ambev wasn't on the list.
While Ambev currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link to see MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.